Reducing the Burden of Radiation
Shorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.
Progress Against Cancer
Shorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.
With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
This month, the editors of the AACR journals highlighted studies about the gut microbiome in lung cancer, modeling the risk of adenoma progression, and more.
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
Chest radiation may not be necessary for people with intermediate-risk breast cancer.
Research finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management strategies.
As we head into the holiday season, Cancer Research Catalyst has tantalizing teasers in the form of science stocking stuffers straight from our November edition of Editors’ Picks. This month, the editors of the...
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now